期刊文献+

尾加压素Ⅱ对肺腺癌A549细胞凋亡的影响及相关机制研究

Effect of Urotensin II on the apoptosis of human lung adenocarcinoma A549 cells and the underlying mechanism
下载PDF
导出
摘要 目的:探讨尾加压素Ⅱ(U-Ⅱ)对肺腺癌A549细胞凋亡的影响及相关机制。方法:将体外培养A549细胞分为正常对照组、顺铂组(25μg/mL)及U-Ⅱ+顺铂组(10-7mol/L U-Ⅱ+25μg/mL顺铂),TUNEL法测定A549细胞凋亡,免疫细胞化学方法检测A549细胞中Bcl-2和Bax的表达。结果:与正常对照组相比,顺铂组肺腺癌A549细胞的凋亡率明显增加,Bcl-2蛋白表达明显降低,Bax表达明显升高(P<0.01);与顺铂组相比,U-Ⅱ则能够抑制A549细胞的凋亡,上调Bcl-2蛋白表达,下调Bax蛋白表达(P<0.01)。结论:U-Ⅱ可通过上调Bcl-2蛋白表达,下调Bax蛋白表达从而抑制肺腺癌A549细胞凋亡。 AIM:To explore the effect of Urotensin II on the apoptosis of human lung adenocarcinoma A549 cells and its underlying mechnism. METHODS: A549 cells were divided into three groups: Control group, Cisplatin group (25 μg/mL)and Urotensin II+Cisplatin group(10-7 mol/L U-Ⅱ+ 25 μg/mL cisplatin). The effect of Urotensin II on the apoptosis of A549 cells was determined by TUNEL method. The expressions of Bcl-2 and Bax were detected by immunocytochemistry. RESULTS:Comparing with Control group, the apoptotic rate and the expression of Bax were increased, while the expression of Bcl-2 was decreased in Cisplatin group(P0.01). Urotensin II significantly inhibited Cisplatin-induced apoptosis of A549 cells and antagonized Cisplatin-induced down-regulation of Bcl-2 and up-regulation of Bax(P0.01). CONCLUSION: Urotensin II inhibits the apoptosis of human lung adenocarcinoma A549 cells by up-regulating the expression of Bcl-2 and down-regulating the expression of Bax.
出处 《中国临床药理学与治疗学》 CAS CSCD 2010年第7期742-746,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 江苏省高校自然科学基金(08KJD310010) 徐州医学院院长专项人才基金(08KJZ05) 徐州医学院肿瘤生物治疗重点实验室开放课题基金(C0804)资助
关键词 尾加压素Ⅱ 肺腺癌 A549 凋亡 BCL-2 BAX Urotensin II Lung adenocarcinoma A549 Apoptosis Bcl-2 Bax
  • 相关文献

参考文献11

  • 1Pearson D, Shively JE, Clark BR, et al. Urotensin Ⅱ:a somatostatin-like peptide in the caudal neurosecretory system of fishes [J]. Proc Natl Acad Sci U S A, 1980, 77 (8): 5021-5024.
  • 2Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the eDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord [J]. Proc Natl Acad Sci U S A, 1998, 95 (26): 15803-15808.
  • 3Ames RS, Sarau HM, Chambers JK, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature, 1999, 401 (6750): 282-286.
  • 4Zhu YC, Zhu YZ, Moore PK. The role of urotensin Ⅱ in cardiovascular and renal physiology and diseases [J]. Br J Pharmacol, 2006, 148 (7): 884- 901.
  • 5Morimoto R, Satoh F, Murakami O, et al. Immunolocalization of urotensin Ⅱ and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues[J]. Peptides, 2008, 29 (5): 873- 880.
  • 6Takahashi K, Totsune K, Murakami O, et al. Expression of urotensin Ⅱ and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin Ⅱ[J]. Peptides, 2003, 24(2): 301-306.
  • 7Shenouda A, Douglas SA, Ohtstein EH, et al. Localization of urotensin-Ⅱ immunoreactiVity in normal human kidneys and renal carcinoma [J]. J Histochem Cytochem, 2002, 50 (7): 885-889.
  • 8Takahashi K, Totsune K, Murakami O, et al. Expression of urotensin Ⅱ and urotensin Ⅱ receptor mRNAs in various human tumor cell lines and secretion of urotensin Ⅱ-like immunoreactivity by SW- 13 adrenocortical carcinoma cells [ J]. Peptides, 2001, 22 (7): 1175-1179.
  • 9祁明信,黄秀榕,胡俊,杨丽英.姜黄素抑制尾加压素-Ⅱ诱导的人晶状体上皮细胞增殖及[Ca^(2+)]_i、cAMP、cGMP信号转导机制[J].中国临床药理学与治疗学,2009,14(10):1085-1090. 被引量:2
  • 10高鸿敏,于忠和,田桂珍,张延利,郝淑玲.尾加压素Ⅱ在肺癌患者血浆中的表达及其临床意义[J].中国肿瘤临床,2009,36(20):1176-1178. 被引量:2

二级参考文献32

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部